Compumedics Ltd
ASX:CMP

Watchlist Manager
Compumedics Ltd Logo
Compumedics Ltd
ASX:CMP
Watchlist
Price: 0.275 AUD Market Closed
Market Cap: AU$54.9m

Gross Margin

53.2%
Current
Improving
by 0.4%
vs 3-y average of 52.9%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
53.2%
=
Gross Profit
AU$31m
/
Revenue
AU$58.3m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
53.2%
=
Gross Profit
AU$31m
/
Revenue
AU$58.3m

Peer Comparison

Country Company Market Cap Gross
Margin
AU
Compumedics Ltd
ASX:CMP
54.9m AUD
Loading...
US
Abbott Laboratories
NYSE:ABT
178.6B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
160.5B USD
Loading...
US
Stryker Corp
NYSE:SYK
126.8B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
111.2B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
93.2B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.1B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
40.6B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.4B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
44B USD
Loading...
US
Resmed Inc
NYSE:RMD
32.6B USD
Loading...

Market Distribution

In line with most companies in Australia
Percentile
66th
Based on 2 544 companies
66th percentile
53.2%
Low
-6 907 100% — 21.6%
Typical Range
21.6% — 58.2%
High
58.2% — 2 095.9%
Distribution Statistics
Australia
Min -6 907 100%
30th Percentile 21.6%
Median 38.3%
70th Percentile 58.2%
Max 2 095.9%

Compumedics Ltd
Glance View

Market Cap
54.9m AUD
Industry
Health Care

Compumedics Ltd. is engaged in the research, development, manufacture and distribution of medical equipment. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-12-21. The firm is engaged in development, manufacture and commercialization of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The firm sells all its product offerings, including sleep diagnostic systems, clinical EEG systems, brain monitoring systems, ultra-sonic blood-flow systems, supplies and technical service and support. The firm sell its products throughout America’s, Australia and Asia Pacific, and Europe and the Middle East regions. Its United States business also includes sleep diagnostic services business. The firm product includes ONsight A.V.S., Grael PSG, Grael LT EEG System, Siesta 802, Grael 4K PSG:EEG, Grael 4K-EEG, Neuvo 64-512 Channel LTM EEG and CURRY. The Company’s subsidiaries include Compumedics USA Ltd, DWL USA Inc., Compumedics USA Inc, Compumedics Telemed Pty Ltd, Compumedics Medical Innovation Pty Ltd, Compumedics Cardiology Pty Ltd.

CMP Intrinsic Value
LOCKED
Unlock
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
53.2%
=
Gross Profit
AU$31m
/
Revenue
AU$58.3m
What is Compumedics Ltd's current Gross Margin?

The current Gross Margin for Compumedics Ltd is 53.2%, which is above its 3-year median of 52.9%.

How has Gross Margin changed over time?

Over the last 3 years, Compumedics Ltd’s Gross Margin has increased from 50.6% to 53.2%. During this period, it reached a low of 50.6% on Dec 31, 2022 and a high of 54.9% on May 30, 2025.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett